coronary interventions Articles
-
The Use of Imaging to Guide Treatment Decisions with Coronary Orbital Atherectomy – Case 2 of 2
Overview Dr. Brock Cookman describes this real-world case to demonstrate the importance of imaging to determine strategy and treatment in complex scenarios and how the unique dual-action mechanism of action (MOA) of the Diamondback 360® Coronary Orbital Atherectomy System sands superficial and fractures deep calcium. Patient History A 78-year-old female patient presented with ...
-
A Contemporary Review of ST-Elevation Myocardial Infarction: Pathophysiology, treatment options and hot topics
Pathophysiology, treatment options and hot topics Improvements In Stemi Treatment The immediate and long-term prognosis of patients experiencing an ST segment elevation myocardial infarction (STEMI) has changed dramatically since the introduction of coronary reperfusion therapies during primary percutaneous coronary intervention (pPCI). The evolution of these therapies accelerated with the ...
-
The Use of Imaging to Guide Treatment Decisions with Coronary Orbital Atherectomy – Case 1 of 2
Overview Dr. Brock Cookman describes this real-world case to demonstrate the importance of imaging to determine strategy and treatment in complex scenarios and how the unique dual-action mechanism of action (MOA) of the Diamondback 360® Coronary Orbital Atherectomy System sands superficial and fractures deep calcium. Patient History A 77-year-old male patient presented with ...
-
Genomadix’s European Scientific Advisory Board Comments on TAILOR-PCI Results
Genomadix’s European Scientific Advisory Board Comments on TAILOR-PCI Results *The largest genetics-based clinical trial in cardiology history supported by Genomadix’s Precision Medicine technology * The results of the TAILOR-PCI trial (Tailored Antiplatelet Initiation to Lessen Outcomes Due to Decreased Clopidogrel Response after Percutaneous Coronary Intervention) were recently ...
By Genomadix
-
A Conversation with Prof. Davide Capodanno, M.D., Ph.D. on the Landmark TAILOR-PCI Clinical Trial Results
After seven years and 5,300-patients tested, the results of the landmark TAILOR-PCI trial were announced in a virtual ACC session. This trial investigated whether a prospective approach using rapid on-site CYP2C19 testing could improve patient outcomes when selecting P2Y12 inhibitor therapy following PCI procedure. This is based on the well-established evidence that approximately 30-50% of ...
By Genomadix
-
How Fluoropolymers are Being Used in Cardiac Procedures
Your three main coronary arteries are responsible for bringing blood to the heart. When they start to become blocked, it can weaken the heart and eventually lead to a heart attack if the blockage isn't addressed and there isn't enough blood supply to the heart. On the left side of the heart, there are two coronary arteries responsible for providing rich blood supply to the heart to ensure it ...
By Fluorostore
-
Physiology and Pathology of Coronary Microcirculation
The heart is a unique organ in many respects since its activity is mandatory to sustain life. The heart’s circulatory system and coronary flow regulation are highly adapted to the vital role of the heart in sustaining life and to everyday physiological challenges. Understanding coronary physiology is key for treating patients with ischemic heart disease in general, and ...
-
Conceptual Considerations for Device-Based Therapy in Acute Decompensated Heart Failure
Abstract Acute decompensated heart failure remains the most common cause of hospitalization in older adults, and studies of pharmacological therapies have yielded limited progress in improving outcomes for these patients. This has prompted the development of novel device–based interventions, classified mechanistically based on the way in which they intend to improve central hemodynamics, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you